Regis Healthcare Ltd (ASX: REG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Regis Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Regis Healthcare Ltd (ASX: REG)
Latest News
Share Gainers
Why Estia Health, Japara, and Regis shares stormed higher on Monday
Share Market News
ASX aged care share prices hammered on Friday as Royal Commission kicks off
Share Fallers
This ASX sector looks set to be a short-selling favourite in 2019
Share Market News
ASX 200 first quarter diary: Everything you need to know
Share Market News
Some of our best loved ASX blue-chips are facing a new emerging risk in 2019
Share Market News
Top brokers name 3 ASX shares to buy today
52-Week Lows
3 ASX shares at 52 week lows: Are they in the bargain bin?
Healthcare Shares
The surprise small-cap winner from the aged care debacle
52-Week Lows
Are these ASX shares too cheap to ignore?
Technology Shares
Is Telstra Corporation Ltd (ASX:TLS) next to face a Royal Commission flogging?
⏸️ Investing
Is it time to top up your holdings of these 3 aged care shares?
Share Market News
ALL ORDINARIES finishes lower Wednesday: 8 shares you missed
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 09 Sep 2025 | $0.0813 | 69.99% | Final | 24 Sep 2025 |
| 13 Mar 2025 | $0.0809 | 59.95% | Interim | 10 Apr 2025 |
| 10 Sep 2024 | $0.0664 | 50.00% | Final | 25 Sep 2024 |
| 14 Mar 2024 | $0.0628 | 50.00% | Interim | 11 Apr 2024 |
| 12 Sep 2023 | $0.0748 | 50.00% | Final | 27 Sep 2023 |
| 16 Mar 2023 | $0.0200 | 50.00% | Interim | 14 Apr 2023 |
| 15 Sep 2022 | $0.0232 | 50.00% | Final | 30 Sep 2022 |
| 10 Mar 2022 | $0.0352 | 50.00% | Interim | 08 Apr 2022 |
| 15 Sep 2021 | $0.0463 | 50.11% | Final | 30 Sep 2021 |
| 10 Mar 2021 | $0.0200 | 50.00% | Interim | 08 Apr 2021 |
| 11 Mar 2020 | $0.0402 | 50.00% | Interim | 30 Sep 2020 |
| 11 Sep 2019 | $0.0711 | 100.00% | Final | 26 Sep 2019 |
| 13 Mar 2019 | $0.0812 | 100.00% | Interim | 11 Apr 2019 |
| 11 Sep 2018 | $0.0865 | 100.00% | Final | 26 Sep 2018 |
| 13 Mar 2018 | $0.0928 | 100.00% | Interim | 11 Apr 2018 |
| 01 Sep 2017 | $0.0000 | 100.00% | Final | 18 Sep 2017 |
| 03 Mar 2017 | $0.1030 | 100.00% | Interim | 20 Mar 2017 |
| 02 Sep 2016 | $0.0594 | 100.00% | Final | 19 Sep 2016 |
| 03 Mar 2016 | $0.0940 | 100.00% | Interim | 21 Mar 2016 |
| 03 Mar 2004 | $0.0700 | 100.00% | Interim | 24 Mar 2004 |
REG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Regis Healthcare Ltd
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
REG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 Jan 2026 | $7.03 | $0.08 | 1.15% | 555,168 | $6.85 | $7.03 | $6.85 |
| 13 Jan 2026 | $6.95 | $0.04 | 0.58% | 700,286 | $7.00 | $7.00 | $6.88 |
| 12 Jan 2026 | $6.91 | $0.02 | 0.29% | 624,378 | $6.91 | $6.94 | $6.82 |
| 09 Jan 2026 | $6.89 | $-0.10 | -1.43% | 900,172 | $7.03 | $7.08 | $6.84 |
| 08 Jan 2026 | $6.99 | $0.03 | 0.43% | 871,643 | $6.94 | $7.04 | $6.92 |
| 07 Jan 2026 | $6.96 | $0.17 | 2.50% | 949,278 | $6.78 | $6.99 | $6.78 |
| 06 Jan 2026 | $6.79 | $-0.11 | -1.59% | 1,798,429 | $6.90 | $7.04 | $6.76 |
| 05 Jan 2026 | $6.90 | $-0.05 | -0.72% | 956,961 | $7.00 | $7.01 | $6.78 |
| 02 Jan 2026 | $6.95 | $0.00 | 0.00% | 271,840 | $7.01 | $7.01 | $6.83 |
| 31 Dec 2025 | $6.95 | $-0.01 | -0.14% | 1,029,701 | $6.99 | $7.03 | $6.91 |
| 30 Dec 2025 | $6.96 | $-0.02 | -0.29% | 792,314 | $7.00 | $7.06 | $6.92 |
| 29 Dec 2025 | $6.98 | $-0.04 | -0.57% | 878,836 | $7.12 | $7.15 | $6.88 |
| 24 Dec 2025 | $7.02 | $-0.02 | -0.28% | 528,687 | $7.04 | $7.04 | $6.91 |
| 23 Dec 2025 | $7.04 | $-0.15 | -2.09% | 1,673,885 | $7.15 | $7.21 | $7.02 |
| 22 Dec 2025 | $7.19 | $-0.13 | -1.78% | 1,032,106 | $7.32 | $7.41 | $7.12 |
| 19 Dec 2025 | $7.32 | $0.05 | 0.69% | 946,150 | $7.24 | $7.36 | $7.23 |
| 18 Dec 2025 | $7.27 | $0.02 | 0.28% | 359,885 | $7.25 | $7.29 | $7.03 |
| 17 Dec 2025 | $7.25 | $-0.12 | -1.63% | 455,518 | $7.31 | $7.33 | $7.15 |
| 16 Dec 2025 | $7.37 | $-0.08 | -1.07% | 413,894 | $7.43 | $7.46 | $7.25 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Dec 2025 | Linda Mellors | Issued | 115,236 | $916,126 |
Issue of securities. 629,324 Rights. No cash consideration is payable. 115,236 Performance Rights issued under the FY26 LTI plan.
|
| 17 Oct 2025 | Linda Mellors | Cancelled | 4,688 | $30,237 |
Cancellation of securities. 514,088 Rights
|
| 13 Oct 2025 | Linda Mellors | Exercise | 419,690 | $2,736,378 |
Conversion of securities. 5,05,020 Rights
|
| 13 Oct 2025 | Linda Mellors | Issued | 419,690 | $2,736,378 |
Conversion of securities.
|
| 13 Oct 2025 | Linda Mellors | Issued | 13,756 | $89,689 |
Conversion of securities. 518,776 Rights
|
| 02 Sep 2025 | Sally Freeman | Buy | 4,805 | $37,440 |
On-market trade.
|
| 29 Aug 2025 | Graham Hodges | Buy | 22,000 | $170,588 |
On-market trade.
|
| 29 Aug 2025 | Graham Hodges | Transfer | 110,000 | $863,500 |
Off-market transfer. Assuming off market transfer of shares
|
| 29 Aug 2025 | Graham Hodges | Transfer | 110,000 | $863,500 |
Off-market transfer. Assuming off market transfer of shares
|
| 27 Aug 2025 | Jodie Leonard | Buy | 12,500 | $98,750 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Graham Hodges | Non-Executive DirectorNon-Executive Chairman | Aug 2017 |
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for approximately 10 years before being seconded to the International Monetary Fund in Washington for several years. He built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. He is currently a Non-Executive Director of Assemble Holdco 1 Pty Ltd and Non Executive Director of Australia and New Zealand Banking Group Limited and ANZ BH Pty Ltd. He was previously Chair of ANZ SAM Board, Esanda, and ANZ Wealth, a Director of AmBank Holdings Berhad and a member of the Australian Governments Aged Care Financing Authority. He is Member of the People and Risk and Compliance Committee.
|
| Professor Christine Constance Bennett | Non-Executive Director | Mar 2018 |
Professor Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. She was awarded the title of Emeritus Professor at the University of Notre Dame Australia following her contributions as Deputy Vice Chancellor Enterprise & Partnerships and Dean of Medicine, Sydney for more than 10 years. Previously, she was Chair of Research Australia, a Group Executive and Chief Medical Officer at both MBF Limited and Bupa Australia, a Partner in the KPMG Health and Life Sciences Practice, CEO of Westmead Hospital, Chair of the Sydney Childrens Hospitals Network, Chair of the National Health and Hospitals Reform Commission, Non-Executive Director of Digital Health CRC Limited and on the Telstra Health Board. She is currently a Non Executive Director of Sonic Healthcare Ltd, Patron of Research Australia, on the Board of the Australian Digital Health Agency, and Convenor of the Champions of Change STEM and Health Group for gender equality. He was awarded an Officer of the Order of Australia in 2014, in recognition of her distinguished service to medicine and health care leadership. She is Chair of the Clinical Governance and Care Committee and Member of the Risk and Compliance Committee and Member of the Property Committee.
|
| Mr Ian Gregory Roberts | Non-Executive Director | May 2007 |
Mr Roberts was a Director of Regis upon listing on 7 October 2014. Prior to listing, he had been a Director of Fairway Investment Holdings Pty Ltd1 since May 2007. Before co leading the Regis journey, he was involved in property development in South East Queensland. As a founding shareholder and Director of Regis, he headed up Property with oversight of the development and implementation of the strategy that saw the business grow to more than 4,500 beds nationally. He has over 35 years of experience in the real estate sector including more than 25 years in residential aged care. He is currently a Non Executive Director of several property and property services enterprises. He is Chair of Property Committee and Member of the People Committee.
|
| Ms Jodie Lee Leonard | Non-Executive Director | Nov 2023 |
Ms Leonard is an experienced listed company director and commercial leader with a focus on strategic marketing and digital transformation. Her career spans over 30 years in ASX, NYSE and FTSE listed companies and includes senior positions at General Electric, the Nine Network, British Airways and Telstra, having worked across Australia, the USA, UK, Asia and Europe. She has experience in a diverse range of industries including banking and financial services, superannuation, healthcare, technology, consumer goods, media and entertainment, and travel and tourism. She currently sits on the board of Barwon Water Corporation. She has previously served on the boards of Pacific Smiles Group Ltd, Beyond Bank Australia, the RACV, Flexigroup and BWX. She is actively involved with Women on Boards and Chairs the NED Circle syndicate. She is Chair of the People Committee and Member of the Property Committee and Clinical Governance Committee
|
| Dr Linda Jane Mellors | Chief Executive OfficerManaging Director | Aug 2019 |
Dr Mellors has been a chief executive for almost 15 years with broad experience in health and aged care, including substantial growth and transformation execution. She is a Director of Ageing Australia and is a member of the Finance and Risk Management Committee. She is also a Board Director of Mercy Community Services Ltd and its subsidiaries including Mackillop Family Services, and a member of the Governance Committee. She was formerly Chair of the Aged Care Reform Network, the Aged Care Guild, and the North Eastern Metropolitan Integrated Cancer Service, Co Chair of the Victorian Metropolitan Hospital Chief Executive group, Board Member of the Parent Infant Research Institute and Board Director of the South West Melbourne Medicare Local. She is also a Fellow of the Williamson Community Leadership Program and a member of Chief Executive Women. She is Member of the Property Committee.
|
| Ms Sally Margaret Freeman | Non-Executive Director | Jan 2022 |
Ms Freeman chairs Regis Audit, Risk and Compliance Committee. She has experience in governance, risk and audit, with an executive career spanning 30 years, culminating in being the Partner in Charge of KPMG Australias Risk Consulting practice and a member of KPMGs Global Risk Executive. She is currently a Non Executive Director at Eastern Health, Regional Investment Corporation, Melbourne Football Club, Suburban Rail Loop Authority and ASX listed Netwealth Group Limited, Netwealth Superannuation Services Pty Ltd. She was previously Director of Aioi Nissay Dowa Insurance Company Australia Pty Ltd and was the Chair of their Board. She is a member of Chief Executive Women. She is Chair of the Risk and Compliance Committee and Member of the People and Clinical Governance and Care Committee.
|
| Mr Malcolm Peter Ross | Company SecretaryGeneral Counsel | Nov 2021 |
-
|
| Rick Rostolis | Chief Financial Officer |
-
|
|
| Malcolm Peter Ross | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Galabay Pty Ltd Acn 010 849 153 | 81,910,479 | 27.19% |
| Hsbc Custody Nominees (Australia) Limited | 57,904,128 | 19.22% |
| Citicorp Nominees Pty Limited | 45,843,568 | 15.22% |
| Ashburn Pty Ltd Acn 005 883 438 | 32,205,238 | 10.69% |
| J P Morgan Nominees Australia Pty Limited | 30,127,423 | 10.00% |
| UBS Nominees Pty Ltd | 4,928,417 | 1.64% |
| BNP Paribas Noms Pty Ltd | 3,658,466 | 1.21% |
| Mandala Holdings Pty Ltd | 3,180,000 | 1.06% |
| Warbont Nominees Pty Ltd | 1,940,289 | 0.64% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 1,912,254 | 0.63% |
| Bki Investment Company Limited | 1,807,428 | 0.60% |
| Galabay Pty Ltd Acn 010 849 153 1 | 1,751,468 | 0.58% |
| National Nominees Limited | 1,629,406 | 0.54% |
| Neweconomy Com Au Nominees Pty Limited | 1,596,153 | 0.53% |
| Mr Vincent Michael O'Sullivan | 1,492,000 | 0.50% |
| Merrill Lynch (Australia) Nominees Pty Limited | 1,381,610 | 0.46% |
| HSBC Custody Nominees (Australia) Limited Gsco Eda | 1,363,526 | 0.45% |
| BNP Paribas Noms Pty Ltd 1 | 1,270,629 | 0.42% |
| BNP Paribas Nominees Pty Ltd | 1,106,128 | 0.37% |
| HSBC Custody Nominees (Australia) Limited 1 | 1,057,128 | 0.35% |